{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:20:03Z","timestamp":1760145603976,"version":"build-2065373602"},"reference-count":21,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>The Hodgkin variant Richter syndrome (HvRS) is an infrequent complication occurring in 1% of lymphocytic lymphoma\/chronic lymphocytic leukemia patients. We report a case of HvRS diagnosed in Sub-Saharan Africa. A 63-year-old patient was consulted for the investigation of an abdominal mass that had been evolving for 5 years prior to admission. His history revealed night sweats, 13% weight loss in 3 months and persistent pruritis. Examination revealed bilateral cervical axillary and inguinal macroadenopathies, painless abdominal distension, pruritic lesions and WHO 2 PS. The blood count showed anemia at 9.5 g\/dL. Histology revealed a lymphomatous proliferation of diffuse architecture, nodular in places, with Hodgkin and Sternberg cells associated with small lymphocytes, histiocytes and eosinophilic polymorphs. Immunohistochemistry showed CD20, PAX5, BCL2, CD5, CD23 and MYC positivity; Ki67 at 10% and cyclin D1, BCL6 and CD10 negativity; CD30 positivity on Hodgkin and Sternberg cells that remained CD20 negative; difficulty interpreting CD15; EBV positivity (EBERs); and CD3 and CD5 positivity on reactive T cells. CD138 and kappa and lambda light chains were non-contributory. The extension work-up classified the patient as Ann Arbor stage III B with a Hasenclever score of 3\/7. This case illustrates the difficulties in diagnosing HvRS in our countries, where the number of haematopathologists is insufficient and the technical facilities are limited.<\/jats:p>","DOI":"10.3390\/hematolrep16030050","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T18:21:40Z","timestamp":1722882100000},"page":"523-528","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lymphocytic Lymphoma Transforming into Hodgkin Lymphoma in Sub-Saharan Africa: Case Report and Literature Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0251-1368","authenticated-orcid":false,"given":"Sokhna A\u00efssatou","family":"Tour\u00e9","sequence":"first","affiliation":[{"name":"Hematology Department, Cheikh Anta Diop University, Dakar 10700, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dibor","family":"Niang","sequence":"additional","affiliation":[{"name":"Pathology Department, Gaston Berger University, Saint-Louis 234, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serigne Mourtalla","family":"Gueye","sequence":"additional","affiliation":[{"name":"Clinical Hematology Unit, National Blood Transfusion Center, Dakar 5002, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Keita","sequence":"additional","affiliation":[{"name":"Hematology Department, Cheikh Anta Diop University, Dakar 10700, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alioune Badara","family":"Diallo","sequence":"additional","affiliation":[{"name":"Hematology Department, Cheikh Anta Diop University, Dakar 10700, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elimane Seydi","family":"Bousso","sequence":"additional","affiliation":[{"name":"Hematology Department, Cheikh Anta Diop University, Dakar 10700, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Dieng","sequence":"additional","affiliation":[{"name":"Clinical Hematology Unit, National Blood Transfusion Center, Dakar 5002, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blaise Felix","family":"Faye","sequence":"additional","affiliation":[{"name":"Hematology Department, Cheikh Anta Diop University, Dakar 10700, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moussa","family":"Seck","sequence":"additional","affiliation":[{"name":"Hematology Department, Cheikh Anta Diop University, Dakar 10700, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saliou","family":"Diop","sequence":"additional","affiliation":[{"name":"Hematology Department, Cheikh Anta Diop University, Dakar 10700, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e932904","DOI":"10.12659\/AJCR.932904","article-title":"Rare Richter Transformation of Chronic Lymphocytic Lymphoma to Hodgkin Lymphoma","volume":"22","author":"Buckley","year":"2021","journal-title":"Am. J. Case Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2012.09127.x","article-title":"Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribine","volume":"158","author":"Jamroziak","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Tadmor, T., and Levy, I. (2021). Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents. Cancers, 13.","DOI":"10.3390\/cancers13205141"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/hematology.2022000345","article-title":"Treatment of Richter\u2019s syndrome","volume":"2022","author":"Thompson","year":"2022","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/17474086.2016.1199948","article-title":"Richter transformation of CLL","volume":"9","author":"Jain","year":"2016","journal-title":"Expert Rev. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.mehy.2005.09.007","article-title":"Hodgkin\u2019s disease variant of Richter\u2019s syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL","volume":"66","author":"Tzankov","year":"2006","journal-title":"Med. Hypotheses"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ajh.23939","article-title":"Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma: Hodgkin transformation of CLL","volume":"90","author":"Parikh","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.11604\/pamj.2019.34.84.18752","article-title":"Caract\u00e9ristiques de la leuc\u00e9mie lympho\u00efde chronique au Togo","volume":"34","author":"Padaro","year":"2019","journal-title":"Pan. Afr. Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hon.3106","article-title":"Richter transformation in Chronic Lymphocytic Leukemia","volume":"41","author":"Innocenti","year":"2023","journal-title":"Hematol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/jnci\/84.18.1422","article-title":"Second Cancers in patients With Chronic Lymphocytic Leukemia","volume":"84","author":"Travis","year":"1992","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/cncr.22121","article-title":"Hodgkin transformation of chronic lymphocytic leukemia: The M. D. Anderson Cancer Center experience","volume":"107","author":"Tsimberidou","year":"2006","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2141.2011.08907.x","article-title":"Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: A retrospective analysis of world literature: Hodgkin Lymphoma as Richter transformation","volume":"156","author":"Bockorny","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood.V122.21.2867.2867","article-title":"Heritable Predisposition To Richter Syndrome in Patients With Chronic Lymphocytic Leukemia","volume":"122","author":"Parikh","year":"2013","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V95.3.1023.003k07_1023_1031","article-title":"Hodgkin and Reed-Sternberg\u2013like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell\u2013derived clones: Potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin\u2019s disease","volume":"95","author":"Kanzler","year":"2000","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199209000-00004","article-title":"Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma with Reed-Sternberg\u2013Like Cells and Possible Transformation to Hodgkin\u2019s Disease: Mediation by Epstein-Barr Virus","volume":"16","author":"Momose","year":"1992","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_16","first-page":"785","article-title":"Hodgkin\u2019s variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group","volume":"34","author":"Tadmor","year":"2014","journal-title":"Anticancer. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ajh.10300","article-title":"Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin\u2019s disease: Case report and literature review","volume":"72","author":"Adiga","year":"2003","journal-title":"Am. J. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein\u2013Barr Virus and the Origins of Associated Lymphomas","volume":"350","author":"Gross","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcp.10263","article-title":"Epstein-Barr virus: Induction and control of cell transformation","volume":"196","author":"Dolcetti","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"509296","DOI":"10.1155\/2012\/509296","article-title":"Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies","volume":"2012","author":"Ghosh","year":"2012","journal-title":"Adv. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11912-022-01274-4","article-title":"Richter\u2019s Transformation","volume":"24","author":"Sigmund","year":"2022","journal-title":"Curr. Oncol. Rep."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/16\/3\/50\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:30:09Z","timestamp":1760110209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/16\/3\/50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["hematolrep16030050"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep16030050","relation":{},"ISSN":["2038-8330"],"issn-type":[{"type":"electronic","value":"2038-8330"}],"subject":[],"published":{"date-parts":[[2024,8,5]]}}}